Stocks of DSS Inc. (AMEX:DSS) traded higher last session on Wall Street, up 0.46% to $0.22.
According to the data, DSS Inc. (AMEX:DSS) has 1 analysts covering its stock. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $3.00 and a low of $3.00, we find $3.00. Given the previous closing price of $0.22, this indicates a potential upside of 1263.64 percent. DSS stock price is now -17.64% away from the 50-day moving average and -43.12% away from the 200-day moving average. The market capitalization of the company currently stands at $29.33M.
A total of 0 analysts have issued a hold rating and 1 have given it a buy rating. Brokers who have rated the stock have averaged $3.00 as their price target over the next twelve months.
With the price target of $14, Aegis Capital recently initiated with Buy rating for DSS Inc. (AMEX: DSS). On July 22, 2013, Dawson James recently initiated its ‘Buy’ rating on the stock quoting a target price of $4.
In other news, Wu William Wai Leung, Director bought 5,000 shares of the company’s stock on Jun 17. The stock was bought for $1,888 at an average price of $0.38. Upon completion of the transaction, the Director now directly owns 151,020 shares in the company, valued at $33224.4. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 16, Director Wu William Wai Leung bought 5,000 shares of the business’s stock. A total of $1,900 was incurred on buying the stock at an average price of $0.38. This leaves the insider owning 146,020 shares of the company worth $32124.4. A total of 58.67% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in DSS stock. A new stake in DSS Inc. shares was purchased by SUSQUEHANNA INTERNATIONAL GROUP, LLP during the first quarter worth $15,000. HRT FINANCIAL LP invested $9,000 in shares of DSS during the first quarter. In the first quarter, NEWMAN DIGNAN & SHEERAR, INC. acquired a new stake in DSS Inc. valued at approximately $3,000. VIRTU FINANCIAL LLC acquired a new stake in DSS for approximately $3,000. In total, there are 33 active investors with 2.80% ownership of the company’s stock.
Monday’s opening bell rang with an opening price of $0.2200 for DSS Inc. (AMEX: DSS). During the past 12 months, DSS Inc. has had a low of $0.21 and a high of $1.15. As of last week, the company has a debt-to-equity ratio of 0.42, a current ratio of 1.20, and a quick ratio of 1.10. The fifty day moving average price for DSS is $0.2671 and a two-hundred day moving average price translates $0.3868 for the stock.
The latest earnings results from DSS Inc. (AMEX: DSS) was released for Jun, 2022. According to the Specialty Business Services Company, earnings per share came in at -$0.05, beating analysts’ expectations of -$0.09 by 0.04. This compares to $0.06 EPS in the same period last year. The net profit margin was -93.60% and return on equity was -20.50% for DSS. The company reported revenue of $11.77 million for the quarter, compared to $4.18 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 181.27 percent. For the current quarter, analysts expect DSS to generate $13.14M in revenue.
DSS Inc.(DSS) Company Profile
DSS, Inc. operates in the product packaging, biotechnology, direct, commercial lending, securities and investment management, alternative trading, digital transformation, secure living, and alternative energy businesses worldwide. It manufactures, markets, and sells custom folding cartons, mailers, photo sleeves, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. The company also invests in or acquires companies in the biohealth and biomedical fields, including businesses that focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases; and develops open-air defense initiatives for air-borne infectious diseases comprising tuberculosis and influenza. In addition, it focuses on acquiring equity positions in undervalued commercial banks, bank holding companies, and nonbanking licensed financial companies; and companies engaged innonbanking activities related to banking, including loan syndication services, mortgage banking, trust and escrow services, banking technology, loan servicing, equipment leasing, problem asset management, special purpose acquisition company consulting, and advisory capital raising services. Further, the company provides securities and investment management services, as well as operates a real estate investment trust for acquiring hospitals and other acute or post-acute care centers; and focuses on developing healthy living communities. Additionally, it develops and/or acquires assets and investments in the securities trading and/or funds management arena, as well as operates as a digital assets broker dealer; and offers solar farms, solar battery banks, and residential energy creation and storage services. The company was formerly known as Document Security Systems, Inc. and changed its name to DSS, Inc. in September 2021. DSS, Inc. was incorporated in 1984 and is headquartered in West Henrietta, New York.